跳至主要内容
临床试验/JPRN-UMIN000003534
JPRN-UMIN000003534已完成3 期

A non-randomized confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma (JCOG 0909,EC-CRT+Salvage-sP3) - A non-randomized confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma (JCOG 0909,EC-CRT+Salvage-sP3)

Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 95 人开始时间: 2010年4月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2) Active infection requiring systemic therapy 3) fever over 38 degrees Celsius 4) Pregnant or lactating women or women of childbearing potential 5) Psychosis 6) Patients requiring systemic steroids medication 7) Serum HBs antigen positive 8) Diabetes mellitus with HbA1c of 7.0% or higher 9) Uncontrollable hypertention 10) Unstable angina within 3 weeks, or with a history of myocardial infarction within 6 months. 11) Interstitial pneumonia, fibroid lung, or severe emphysema 12) With a history of cerebrovascular disorder within 6 months 13) Drug allergy for iodic drug

研究者

发起方
Japan Clinical Oncology Group(JCOG)

相似试验

A non-randomized confirmatory study of definitive... | 临床试验